Henlez
Advancing treatments for chronic dermatological conditions
Henlez has raised €1.0M across 1 funding round from 2 investors, most recently a Seed round in Oct 2022. Based in Denmark; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.0M
€996,314
Funding rounds
1
Investors
2
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearHenlez — funding by year — interactive chart.
Data table
| Henlez — funding by year | |
|---|---|
| 2022 | €1.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-27 | Seed | €1.0M | EIR Ventures,Karolinska Development | View deal → |
Investors
2Related news
- Henlez Raises €1M in Seed Fundingfinsmes.com · 2022-10
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData